Radiation InjuriesRadiation DosageRadiation, IonizingDose-Response Relationship, RadiationRadiation ToleranceRadiotherapyRadiotherapy DosageRadiationAntineoplastic AgentsCombined Modality TherapyRadiation ProtectionRadiation OncologyRadiotherapy, ConformalRadiation MonitoringRadiotherapy, Intensity-ModulatedDose FractionationRadiotherapy, AdjuvantRadiotherapy Planning, Computer-AssistedRadiation PneumonitisNeoplasmsBrachytherapyRadiometryTreatment OutcomeCell Line, TumorRadiation-Sensitizing AgentsNeoplasms, Radiation-InducedRadiation Injuries, ExperimentalRadiosurgeryGamma RaysDrug Screening Assays, AntitumorCosmic RadiationBrain NeoplasmsRadiotherapy, Computer-AssistedCisplatinDoxorubicinCranial IrradiationNeoplasm Recurrence, LocalParticle AcceleratorsRadiotherapy, Image-GuidedApoptosisHead and Neck NeoplasmsBackground RadiationRadiation-Protective AgentsTime FactorsRadiodermatitisBreast NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsCell SurvivalRetrospective StudiesNeoplasm StagingRadiotherapy, High-EnergyUltraviolet RaysOrgans at RiskDNA DamageDrug Resistance, NeoplasmProstatic NeoplasmsCarcinoma, Squamous CellAntineoplastic Agents, PhytogenicSurvival AnalysisFollow-Up StudiesRadiation EffectsCobalt RadioisotopesChemoradiotherapyTomography, X-Ray ComputedAdenocarcinomaSurvival RateDisease-Free SurvivalFluorouracilRadiobiologyMice, NudeXenograft Model Antitumor AssaysLung NeoplasmsTumor Cells, CulturedTumor BurdenPrognosisAntibiotics, AntineoplasticEtoposideX-RaysMastectomy, SegmentalChemotherapy, AdjuvantDrug Delivery SystemsAcute Radiation SyndromePaclitaxelGlioblastomaCell ProliferationActuarial AnalysisDose-Response Relationship, DrugLinear Energy TransferClinical Trials as TopicDacarbazineLymphatic IrradiationRadioactive Hazard ReleaseDNA RepairFour-Dimensional Computed TomographyVincristineDrug CarriersRelative Biological EffectivenessGliomaRadiation Hybrid MappingCarcinoma, Non-Small-Cell Lung